MRCVX Fees and Costs — MassMutual 20/80 Allocation Fund, Class R3

Data updated: 2025-08-25

The net expense ratio is 1.27%. There are no sales loads or redemption fees. Portfolio turnover was 16%.

MRCVX Fees and Expenses

Annual operating expenses and sales charges of MRCVX. Prospectus, as of January 31, 2025.

Annual operating expenses
Management fee0.00%
12b-1 fee0.50%
Other expenses0.34%
Gross expense ratio1.27%
Fee waiver—
Net expense ratio1.27%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

MRCVX Costs Over Time

On $10,000 invested in MRCVX, assuming 5% a year before costs, total costs come to $790 over 5 years, cutting the return by 1.33% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.27%)$133$415$717
Lost growth on money paid in costs$0$21$73
Total costs$133$435$790
Value after costs$10,367$11,141$11,973
Impact on return, per year1.33%1.33%1.33%

MRCVX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $67.4M
  • Portfolio turnover (prospectus): 16%
  • Securities lending: none during the year

MRCVX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Fund of Funds$67.4M100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.